MAP3K7 and acute lymphoblastic leukemia: To analyze the biological effects of a reduced MAP3K7 expression, we chose three T-ALL cell lines (CCRF-CEM, Jurkat, MOLT-4) that do not carry a MAP3K7 deletion as assessed by MLPA.